Main menu
AMP 2025
12 - 15 November 2025 EST
Boston, Massachusetts, United States

Oxford Nanopore at AMP 2025

The Association for Molecular Pathology (AMP) Annual Meeting & Expo features more than 200 exhibiting companies, 60 educational sessions, nearly 400 poster presentations, and 3,000+ attendees/exhibitors.

Oxford Nanopore will be located at Booth 1510, and will host 2 Corporate Workshops on Wednesday, November 12 at 12:00 pm and 2:00 pm EST. Exhibits will be open from November 13 to November 15.

Register for Oxford Nanopore Corporate Workshops at AMP 2025
boston-color-2

Corporate Workshop 1

Oxford Nanopore Technologies: Revolutionizing Oncology with Comprehensive Multiomic Sequencing Solutions

Join us on Corporate Workshop Day to explore how Oxford Nanopore’s multiomic sequencing solutions are transforming oncology. Learn how real-time, any-read length sequencing can enable comprehensive oncology assays. Discover how a single assay can detect SNVs, indels, structural variants, copy number changes, and methylation — with native DNA or RNA sequencing. Whether leveraging adaptive sampling for hereditary cancer panels or direct DNA sequencing for tumor methylation classification, Oxford Nanopore sequencing empowers streamlined, scalable insights across the cancer continuum.

Date: Wednesday, November 12, 2025

Time: 12:00 pm-12:50 pm EST

Location: Room 155, Level 1, Boston Convention and Exhibition Center

Speakers

picture of Ellie Juarez

Updates from Oxford Nanopore

Ellie Juarez, Oxford Nanopore Technologies

...

picture of Areeba Patel, PhD

Rapid comprehensive molecular profiling of CNS tumors

Areeba Patel, PhD, German Cancer Research Center, Heidelberg

...

picture of  Francisco Marchi, PhD

Epigenomic diagnosis and prognosis of Acute Myeloid Leukemia

Francisco Marchi, PhD, ALMA Genomics Inc

Francisco was born and raised in Brazil and is a cancer survivor dedicated to advancing precision me...

Corporate Workshop 2

Oxford Nanopore Technologies: Unlocking hidden genomic regions for rare disease research

Join us on Corporate Workshop Day to explore how Oxford Nanopore's unrestricted read length sequencing technology is transforming rare disease research and human genome analysis. Discover how Oxford Nanopore sequencing captures comprehensive genomic variation—including structural variants, repeat expansions, and epigenetic modifications. Learn how the latest applications using Oxford Nanopore long-read technology are accessing previously difficult-to-sequence genomic regions to advance rare disease research and unlock new insights into human genetic variation.

Date: Wednesday, November 12, 2025

Time: 02:00 pm-02:50 pm PST

Location: Room 156AB, Level 1, Boston Convention and Exhibition Center

Speakers

picture of Alex Lindell

Updates from Oxford Nanopore

Alex Lindell, Oxford Nanopore Technologies

Alex Lindell is Senior Director of Clinical Solutions at Oxford Nanopore Technologies, where he lead...

picture of Brian Haynes

Long-Range PCR Meets Long-Read Sequencing to Resolve Challenging ACMG Tier 3 Carrier Screening Genes

Brian Haynes, CSO, Asuragen, a Bio-Techne Brand

...

picture of Dr. Scott Hickey

Oxford Nanopore-Based Structural and Epigenetic Profiling of D4Z4 Arrays in FSHD

Dr. Scott Hickey, Oxford Nanopore Technologies

Scott Hickey is Senior Director of Commercial Applications at Oxford Nanopore, where he leads global...

Register

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Spanish flag